Abstract Post-transplant Lymphoproliferative Disease (PTLD) remains a major complication
of solid organ transplantation (SOT) in pediatric patients. The majority are Epstein-Barr Virus …

Context.—Posttransplant lymphoproliferative disorder (PTLD) remains a significant
complication in pediatric patients undergoing solid organ transplant (SOT). The majority …

Simple Summary Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-
threatening complication of mainly solid organ and, less frequently, allogeneic …

Post-transplant lymphoproliferative disease (PTLD) is the most common malignancy
complicating solid organ transplantation (SOT) in adults and children. PTLD encompasses a …

Post-transplant lymphoproliferative disorders are a well-recognized complication of solid
organ and stem cell transplantation. Much data has accumulated with respect to the …

With the advancement of immunosuppressive strategies, the outcome of liver transplantation
during childhood has dramatically improved. On the other hand, Epstein–Barr virus (EBV) …

Abstract The International Pediatric Transplant Association (IPTA) Consensus Conference
on Practice Guidelines for the Diagnosis, Prevention, and Management of Post‐Transplant …

Post‐transplant lymphoproliferative disease (PTLD) remains a major complication of
transplantation. PTLD is a rare entity and very heterogenous making consensus on …

Background Epstein-Barr virus (EBV) specific T-cell response measurement can help adjust
immunosuppression in transplant patients with persistent infections. We aim to define T-cell …

Introduction Post‐transplant lymphoproliferative disorder (PTLD) is a clinically
heterogeneous potentially fatal complication of pediatric liver transplantation (PLT). We …